Synopsis
0
CEP/COS
0
JDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
12
PharmaCompass offers a list of Levamlodipine Besilate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Levamlodipine Besilate manufacturer or Levamlodipine Besilate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Levamlodipine Besilate manufacturer or Levamlodipine Besilate supplier.
PharmaCompass also assists you with knowing the Levamlodipine Besilate API Price utilized in the formulation of products. Levamlodipine Besilate API Price is not always fixed or binding as the Levamlodipine Besilate Price is obtained through a variety of data sources. The Levamlodipine Besilate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Levamlodipine Besilate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Levamlodipine Besilate, including repackagers and relabelers. The FDA regulates Levamlodipine Besilate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Levamlodipine Besilate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Levamlodipine Besilate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Levamlodipine Besilate supplier is an individual or a company that provides Levamlodipine Besilate active pharmaceutical ingredient (API) or Levamlodipine Besilate finished formulations upon request. The Levamlodipine Besilate suppliers may include Levamlodipine Besilate API manufacturers, exporters, distributors and traders.
click here to find a list of Levamlodipine Besilate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Levamlodipine Besilate DMF (Drug Master File) is a document detailing the whole manufacturing process of Levamlodipine Besilate active pharmaceutical ingredient (API) in detail. Different forms of Levamlodipine Besilate DMFs exist exist since differing nations have different regulations, such as Levamlodipine Besilate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Levamlodipine Besilate DMF submitted to regulatory agencies in the US is known as a USDMF. Levamlodipine Besilate USDMF includes data on Levamlodipine Besilate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Levamlodipine Besilate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Levamlodipine Besilate suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Levamlodipine Besilate Drug Master File in Korea (Levamlodipine Besilate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Levamlodipine Besilate. The MFDS reviews the Levamlodipine Besilate KDMF as part of the drug registration process and uses the information provided in the Levamlodipine Besilate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Levamlodipine Besilate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Levamlodipine Besilate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Levamlodipine Besilate suppliers with KDMF on PharmaCompass.
A Levamlodipine Besilate written confirmation (Levamlodipine Besilate WC) is an official document issued by a regulatory agency to a Levamlodipine Besilate manufacturer, verifying that the manufacturing facility of a Levamlodipine Besilate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Levamlodipine Besilate APIs or Levamlodipine Besilate finished pharmaceutical products to another nation, regulatory agencies frequently require a Levamlodipine Besilate WC (written confirmation) as part of the regulatory process.
click here to find a list of Levamlodipine Besilate suppliers with Written Confirmation (WC) on PharmaCompass.
Levamlodipine Besilate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Levamlodipine Besilate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Levamlodipine Besilate GMP manufacturer or Levamlodipine Besilate GMP API supplier for your needs.
A Levamlodipine Besilate CoA (Certificate of Analysis) is a formal document that attests to Levamlodipine Besilate's compliance with Levamlodipine Besilate specifications and serves as a tool for batch-level quality control.
Levamlodipine Besilate CoA mostly includes findings from lab analyses of a specific batch. For each Levamlodipine Besilate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Levamlodipine Besilate may be tested according to a variety of international standards, such as European Pharmacopoeia (Levamlodipine Besilate EP), Levamlodipine Besilate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Levamlodipine Besilate USP).
